The Beachbody Company, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BODI research report →
Range $9 – $9
Price Chart
About the company
The Beachbody Co. , Inc. operates as a health and wellness company.
- CEO
- Carl Daikeler
- IPO
- 2021
- Employees
- 270
- HQ
- El Segundo, CA, US
Get TickerSpark's AI analysis on BODI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.14M
- P/E
- 1.84
- Fwd P/E
- 3.58
- PEG
- 0.00
- P/S
- 0.11
- P/B
- 0.53
- EV/EBITDA
- 0.71
- Div Yield
- 0.00%
- Gross Margin
- 71.93%
- Op Margin
- 6.98%
- Net Margin
- 5.95%
- ROE
- 33.53%
- ROIC
- 20.79%
Latest fiscal year · YoY change
- Revenue
- $251.73M-39.9%
- Gross Profit
- $183.78M-36.0%
- Op Income
- $8.01M
- Net Income
- $-2,860,000+96.0%
- EPS
- $-0.41+96.1%
- OCF Growth
- +748.9%
- FCF Growth
- +976.3%
- 52W High
- $16.87
- 52W Low
- $2.52
- 50D MA
- $4.40
- 200D MA
- $8.64
- Beta
- 0.90
- RSI (14)
- 21
- Avg Volume
- 29.43K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Beachbody posted better-than-guided profitability in Q3, but revenue continued to decline as management leans into a nutrition-first multichannel reset that is taking longer than expected to scale.· November 10, 2026
- Q3 revenue was $45.2 million, down 24.5% year over year, but still within guidance.
- Gross margin held at 70.7%, adjusted EBITDA was $6.4 million, and both beat the high end of guidance.
- Management said the cost reset reduced 2027 anticipated overhead by about $34 million and lowered EBITDA breakeven to about $125 million.
- Digital subscriptions were about 690,000 and nutrition subscriptions about 60,000; retention remained around 95.4% on digital.
- Retail rollout and new-product growth are still early, with management citing planogram timing as a key delay.
- Q4 guidance calls for $38 million to $42 million of revenue and $6 million to $9 million of adjusted EBITDA.
Total revenue was $45.2 million, down 24.5% year over year and 8.9% sequentially. Digital revenue was $27.8 million, down 23.5% year over year, and nutrition and other revenue was $17.4 million, down 26.1% year over year. Consolidated gross margin was 70.7%, down 93 basis points year over year. Operating income was $1.3 million, net income was $3.3 million, and adjusted EBITDA was $6.4 million, with adjusted EBITDA margin at about 14.1%. For Q4 2026, the company expects revenue of $38 million to $42 million, net income of negative $2 million to $1 million, and adjusted EBITDA of $6 million to $9 million. Management expects Q4 revenue mix to be about 64% digital and 36% nutrition and other, with consolidated gross margin of 68% to 70%.
Mark Goldston said the company is executing a financial turnaround better than planned, while the growth turnaround is slower because retail timing is outside its control. He emphasized a nutrition-first strategy, broader pricing flexibility now that the old compensation model is gone, and a push into a much larger supplement market through DTC, Amazon, retail, and distributors like KeHE. His tone was candid but optimistic, repeatedly stressing that the brand portfolio, innovation pipeline, and lower cost structure create long-term upside.
Brad Ramberg said Q3 results were above guidance on profitability even as revenue declined. He detailed that operating expenses fell 22.7% year over year to $30.7 million, cash ended at $27.5 million, debt was about $22.9 million, and net cash was $4.6 million; covenant pressure remains manageable as long as cash stays above $22.5 million. He also said the restructuring reduced 2027 overhead by about $27 million, with another $7 million of savings from media efficiencies and a turnkey production model, and that Q4 will include about $3 million of restructuring expense.
Analysts focused on retail sell-through, new product performance, digital engagement, retention, and how the marketing mix is changing. Management said it would not disclose retailer-specific sell-through, but noted Sprouts expanded to 181 stores, Vitamin Shoppe is in 481 stores, and the Southern California energy drink test is just starting. On digital, management said retention remains around 95%, that returning customers drove much of the quarter’s sales, and that the company is shifting spend away from chasing existing CRM customers toward a more efficient top-of-funnel model for new acquisition.
The positive case is that Beachbody is showing real operating leverage: the business is already profitable, margins remain strong, and the restructuring further lowered the breakeven bar. Management believes the nutrition pivot, expanded retail distribution, Amazon, and new product launches could unlock a much larger addressable market than the legacy model allowed.
The main risk is that growth has not yet followed the strategy shift, with revenue still down sharply year over year and management admitting the turnaround is slower than expected. Retail expansion depends on planogram cycles the company cannot control, digital subscriber counts are falling, and management said much of the current marketing response is still coming from former members rather than new customers.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 46.9%
- Shares Outstanding
- 7.28M
- Float Shares
- 3.42M
of shares held by institutions
55 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Raine Capital LLC | 671.07K | 0 |
| Vanguard Group Inc | 135.43K | ▼ 1.94K |
| Vanguard Capital Management LLC | 123.52K | 0 |
| Msa Advisors, LLC | 90.08K | 0 |
| Blackrock, Inc. | 78.26K | ▲ 144 |
| North Star Investment Management Corp. | 75.00K | 0 |
| Two Sigma Investments, LP | 71.35K | ▲ 35.12K |
| Renaissance Technologies LLC | 69.66K | ▼ 32.80K |
| Informed Momentum Co LLC | 58.61K | ▲ 58.61K |
| Evernest Financial Advisors, LLC | 47.35K | ▲ 18.27K |
| Arrowstreet Capital, Limited Partnership | 40.03K | 0 |
| Geode Capital Management, LLC | 39.69K | ▼ 682 |
Held by 24 ETFs
Biggest fund positions in BODI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 15, 26 | Ramberg Bradley | other | 319 |
| Aug 15, 26 | Ramberg Bradley | other | 3,556 |
| Aug 15, 26 | GOLDSTON MARK R | other | 100,000 |
| Jul 15, 26 | Ramberg Bradley | other | 54 |
| Jun 2, 26 | Lundy Ann Marie | other | 9,182 |
| Jun 2, 26 | Van de Bunt Bennet | other | 9,182 |
| Jun 2, 26 | Frank Kristin E. | other | 9,182 |
| Jun 2, 26 | Mayer Kevin A | other | 9,182 |
| Jun 2, 26 | Salter John S. | other | 9,182 |
| Jun 2, 26 | Conlin Mary Murphy | other | 9,182 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BODI coverage
Recent articles, reports, and earnings notes.
No research on BODI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BODI report →BODi Unleashes Brand New “INSANITY: Unhinged”, an Intense 100-Day Training Program Developed by HYROX World Champion Hunter McIntyre and Executive Produced by Shaun T
businesswire.com · Nov 13
Beachbody: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 12
The Beachbody Company, Inc. in the 17th Annual Craig-Hallum Alpha Select Conference
businesswire.com · Nov 12
The Beachbody Company, Inc. (BODI) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 11
The Beachbody Company, Inc. (BODI) Surpasses Q3 Earnings Estimates
zacks.com · Nov 10
Beachbody (BODi) Reports Third Quarter Financial Results
businesswire.com · Nov 10
BODi Launches Limited-Edition Cinnamon Roll Shakeology with 0g Added Sugar, Delivering Serious Nutrition and Supporting Gut Health in a Dessert-Inspired Flavor
businesswire.com · Nov 4
The Beachbody Company, Inc. Announces Third Quarter 2026 Earnings Release Date, Conference Call, and Webcast
businesswire.com · Nov 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.